Dinazafone
- Level
- Commodity
- Parent
- 51141500
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51141554This classification denotes an anticonvulsant agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 411OG24QOU. European Medicines Agency schedules Dinazafone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07191MIG. Dinazafone generally arises in the molecular formula C20H21CLN2O2. The term DINAZAFONE is an International Non-Proprietary Name or INN. DINAZAFONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule dinazafone under HS 29242995 and SITC 51479. As of Q4 2014, DINAZAFONE remains the US FDA Preferred Term for this commodity. Dinazafone bears US NLM identifiers UMLS ID C1880337 and NCI Concept Code C65411. SMILES: CLC1CC(C(N(C(=O)CNCC(=C)C)C)CC1)C(=O)C1CCCCC1.
Same parent
Under 51141500 · 80Activities that produce or sell this
KBLI · 8Inherited from family 51140000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.